METHYLPREDNISOLONE ACETATE

Post-LOE

methylprednisolone acetate

ANDAINJECTIONINJECTABLE
Approved
Feb 2005
Lifecycle
Post-LOE
Competitive Pressure
30/100
Clinical Trials
1

Clinical Trials (1)

NCT00139295Phase 3Completed

Comparison of Hylastan to Methylprednisolone Acetate in Patients With Symptomatic Osteoarthritis of the Knee

Started Oct 2004
Osteoarthritis, Knee